# US 2025/0084358 A1 · Products of manufacture for cul turing or maintaining normal, pre-cancer and cancer stem and progenitor

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0084358 A1
- Document ID: US20250084358A1
- Status: Published application
- Kind: A1
- Application number: 18/729,810
- Filed: 2023-01-12
- Published: 2025-03-13
- Earliest claimed: 2022-01-12
- Assignees: The Regents of the University of California
- Applicants: The Regents of the University of California
- Inventors: Catriona JAMIESON; Luisa LADEL; JESSICA PHAM; Isabelle OLIVER; Larisa BALAIAN; Christina WU; Wenxue MA; Ludmil ALEXANDROV; Shuvro NANDI; Thomas WHISENANT
- Web page: https://patentgrep.com/patent/US20250084358A1

## CPC

- C12M 23/24: {Gas permeable parts}
- C12M 23/14: {Bags}
- C12M 23/40: {Manifolds; Distribution pieces (fluid transfer means B01L3/563)}
- C12M 25/14: {Scaffolds; Matrices (in general C12N5/0068)}
- C12M 29/12: {Pulsatile flow}
- C12M 35/08: {Chemical, biochemical or biological means, e.g. plasma jet, co-culture}
- C12N 5/0647: {Haematopoietic stem cells; Uncommitted or multipotent progenitors}
- C12N 2513/00: 3D culture
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

In alternative embodiments, provided are biosensing bioreactors that detect normal, pre-cancer and cancer stem cells. In alternative embodiments, provided are bioreactors for primary human hematopoietic stem and progenitor cell culture, manipulation and maintenance, which can comprise micro-peristaltic pumps to recapitulate blood flow. In alternative embodiments, provided are products of manufacture in the form of a bioreactor, or a nanobioreactor, or a customized cell culture bag with a defined three dimensional (3D) stromal microenvironment, and kits comprising them, and methods for making and using them. In alternative embodiments, the products of manufacture as provided herein, including the bioreactor, nanobioreactor, bag, customized cell culture bag and kits as provided herein, are used to and are capable of culturing, maintaining or supporting the culture of, and/or differentiating hematopoietic stem cells, including human hematopoietic stem cells, isolated from bone marrow or blood donors.

## Claims

### Claim 1

A product of manufacture for primary human hematopoietic stem cell culture and/or maintenance, comprising:
a container, enclosure or bag having gas-permeable walls or sides, and a sponge matrix or a sponge-like material contained within the container, enclosure or bag,
wherein the sponge matrix or sponge-like material is infused with a cell culture media and a mixture of cells comprising stem cells and/or bone marrow matrix cells,
and the container, enclosure or bag interior is sterile,
and the container, enclosure or bag comprises at least one liquid or cell input port.

### Claim 2 (depends on 1)

The product of manufacture of claim 1, wherein the container, enclosure or bag is fabricated as a gas-permeable cell culture environment.

### Claim 3 (depends on 1)

The product of manufacture of claim 1, wherein the container, enclosure or bag comprises at least two liquid or cell input ports, one out port and one in port.

### Claim 4 (depends on 3)

The product of manufacture of claim 3, wherein a micro-peristaltic pump for circulating liquid inside the container, enclosure or bag is operably connected to the in port and the out port.

### Claim 5 (depends on 1)

The product of manufacture of claim 1, wherein the mixture of cells comprises stem cells, bone marrow matrix cells, or cancer stem cells, or human cancer stem cells, or organoid cells, or comprising cells from malignant organoids representing solid tumors.

### Claim 6 (depends on 1)

The product of manufacture of claim 1, wherein the mixture of cells comprises CD34+ donor-derived human hematopoietic cells (HSCs), or human CD34+ donor-derived human hematopoietic cells (HSCs).

### Claim 7 (depends on 1)

The product of manufacture of claim 1, wherein the sponge matrix or sponge-like material comprises:
an absorbable gelatin sponge, and/or
a compressed sponge with adsorbable gelatin,

### Claim 8 (depends on 7)

The product of manufacture of claim 7, wherein the sponge or sponge-like material further comprises: a demineralized cancellous bone matrix sponge, or demineralized bone matrix components.

### Claim 9 (depends on 1)

The product of manufacture of any of claims claim 1, wherein between about 106 to about 1010 cells are placed into, or cultured in, the product of manufacture.

### Claim 10 (depends on 1)

The product of manufacture of claim 1, further comprising a detectable vector or reporter, optionally comprising a bioluminescent and/or a fluorescent vector, optionally comprising a bioluminescent and/or a fluorescent lentiviral reporter vector, wherein optionally the bioluminescent and/or a fluorescent vector is capable of quantifying cells or cell function, optionally capable of quantifying normal, pre-cancer and/or cancer stem cell function, optionally the detectable vector or report comprises a FUCCI2BL cell cycle reporter, an ADAR1-nanoluciferase-GFP reporter self-renewal reporter and/or an RFP/GFP splicing reporter.

### Claim 11 (depends on 1)

A method for culturing or maintaining or differentiating a plurality of stem cells comprising placing into or culturing the plurality of stem cells in a product of manufacture of claim 1.

### Claim 12 (depends on 1)

A method for producing an organoid, optionally an malignant organoid representing a solid tumor, optionally breast cancer solid tumor comprising incubating in a product of manufacture of claim 1 a plurality of stem cells, optionally further comprising cytokines capable of differentiating the stem cells.

### Claim 13 (depends on 1)

A kit comprising a product of manufacture of claim 1, optionally further comprising instructions for practicing a method of any of the preceding claims.

### Claim at position 14

14-15. (canceled)

### Claim 16 (depends on 1)

The product of manufacture of claim 1, wherein the container, enclosure or bag having gas-permeable walls or sides is liquid impermeable or liquid impervious.

### Claim 17 (depends on 5)

The product of manufacture of claim 5, wherein the mixture of cells comprises stem cells, or human stem cells.

### Claim 18 (depends on 7)

The product of manufacture of claim 7, wherein the absorbable gelatin sponge comprises an absorbable human or porcine gelatin sponge.

### Claim 19 (depends on 1)

The product of manufacture of claim 1, wherein the sponge matrix or sponge-like material comprises a solubilized or reconstituted basement membrane matrix.

### Claim 20 (depends on 1)

The product of manufacture of claim 1, wherein the sponge matrix or sponge-like material comprises a solubilized or reconstituted laminin/collagen IV-rich basement membrane extracellular matrix.

### Claim 21 (depends on 1)

The product of manufacture of claim 1, wherein the sponge matrix or sponge-like material comprises a hydrogel-based macroporous sponge or porous hydroxipropylcellulose (HPC) scaffold.

### Claim 22 (depends on 5)

The product of manufacture of claim 5, wherein the bone marrow matrix cells comprise human bone marrow matrix cells.
